Search

everythinglearnresearchcommunity

for

Search:↓

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Disrupted cysteine metabolism may cause hair breakage in Alopecia Areata, suggesting potential treatments like N-acetylcysteine.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

Erdr1 could be a new marker for diagnosing hair loss.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Stressful life events may trigger alopecia areata.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Both treatments for alopecia areata showed similar modest effectiveness.

Children with alopecia areata should only get thyroid screening if they have Down syndrome, a family history of thyroid disease, atopy, or signs of thyroid problems.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Cryotherapy may be an effective and simple treatment for mild hair loss with few side effects.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Finasteride for hair loss in young men increases the risk of sexual dysfunction.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

A man's red tattoo caused a skin reaction and hair loss in his beard, which improved after treatment.